Joseph C. Papa's most recent trade in Candel Therapeutics Inc was a trade of 64,239 Common Stock done at an average price of $4.7 . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 4.67 per share. | 25 Jun 2025 | 64,239 | 64,239 | - | 4.7 | 299,996 | Common Stock |
| Candel Therapeutics Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Milestone Pharmaceuticals Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.83 per share. | 13 May 2025 | 60,000 | 342,500 (0%) | 0% | 5.8 | 349,800 | Common Stock |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 250,000 | 1,532,500 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 250,000 | 1,282,500 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 282,500 | 1,032,500 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 282,500 | 282,500 (0%) | 0% | 0 | Common Stock | |
| Milestone Pharmaceuticals Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Candel Therapeutics Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 750,000 | 750,000 | - | - | Employee Stock Options (Right to Buy) | |
| Candel Therapeutics Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Joseph C. Papa | Director | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 08 Dec 2022 | 35,018 | 38,032 | - | 1.9 | 67,935 | Common Stock |
| Candel Therapeutics Inc | Joseph C. Papa | Director | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 08 Dec 2022 | 3,014 | 3,014 | - | 1.7 | 5,124 | Common Stock |
| Candel Therapeutics Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 28,480 | 28,480 | - | - | Stock Option (Right to Buy) |